Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
Featured Articles
Search
Author Details
Jenifer Propets
Lorem ipsum dolor sit amet, adipiscing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.